Antithrombin Attenuates Microvascular Leakage and Leukocyte-Endothelial Interaction in Response to Endotoxin

Boris Leithäuser; Johannes Schumacher; Sven Lendemans; Harald Tillmanns; F. Reinhard Matthias

doi:10.1055/s-2002-30201

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2002; 28(S1): 087-094
DOI: 10.1055/s-2002-30201

Antithrombin Attenuates Microvascular Leakage and Leukocyte-Endothelial Interaction in Response to Endotoxin

Boris Leithäuser, Johannes Schumacher, Sven Lendemans, Harald Tillmanns, F. Reinhard Matthias

Medical Clinic I, Department of Cardiology- Angiology, Justus-Liebig-University, Giessen, Germany

Abstract

Volltext

Referenzen

REFERENCES

1 Rosenberg R D, Bauer K A. The heparin-antithrombin system: a natural anticoagulant mechanism. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice Philadelphia: Lippincott 1994: 837-860
2 Thijs L G, de Boer P J, de Groot C M M, Hack C E. Coagulation disorders in septic shock. Intensive Care Med . 1993; 19 S8-S15
3 Mammen E F. Antithrombin: its physiological importance and role in DIC. Semin Thromb Hemost . 1998; 24 19-25
4 Eisele B, Lamy M. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost . 1998; 24 71-80
5 Balk R A, Emerson T E, Fourrier F. Therapeutic use of antithrombin concentrate in sepsis. Semin Thromb Hemost . 1998; 24 183-194
6 Dickneite G. Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost . 1998; 24 61-69
7 Okajima K, Uchiba M. The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost . 1998; 24 27-32
8 Risberg B. Antithrombin: facts and hypotheses. Blood Coagul Fibrinolysis . 1998; 9(Suppl 3) S3-S6
9 Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol . 1996; 270 L921-L930
10 Welbourn C RB, Young Y. Endotoxin, septic shock, and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg . 1992; 79 998-1003
11 Kirkpatrick C J, Bittinger F, Klein C L, Hauptmann S, Klosterhalfen B. The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective. Virchows Arch . 1996; 427 461-476
12 Nievière R, Mathieu D. Microangiodynamic abnormalities in sepsis. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine New York: Springer 1995: 539-545
13 Menger M D, Vollmar B, Messmer K. Sepsis and nutritional blood flow. In: Reinhart K, Eyrich K, Sprung C, eds. Update in Intensive Care and Emergency Medicine Sepsis-Current Perspectives in Pathophysiology and Therapy Berlin: Springer-Verlag 1994: 163-173
14 McCuskey R S, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res . 1996; 32 752-763
15 Tritto I, Ambrosio G. Spotlight on microcirculation: an update. Cardiovasc Res . 1999; 42 600-606
16 Klyscz T, Jünger M, Jung F, Zeintl H. Cap-Image-ein neuartiges computergestütztes Videobildanalysesystem für die dynamische Kapillarmikroskopie. Biomed Tech (Berl) . 1997; 42 168-175
17 Fourrier F, Jourdain M, Tournois A. Coagulation inhibitor substitution during sepsis. Intensive Care Med . 1995; 21 S254-S268
18 Vinazzer H. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost . 1989; 15 347-352
19 Okano K, Kokudo Y, Okajima K. Protective effects of antithrombin III supplementation on warm ischemia and reperfusion injury in rat liver. World J Surg . 1996; 20 1069-1075
20 Groeneveld A BJ, Raijmakers P GH. Pulmonary dysfunction after remote ischemia and reperfusion. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine New York: Springer 1995: 44-51
21 Dickneite G, Paques E P. Protection of DIC-induced mortality in Klebsiella pneumoniae-infected and LPS-treated rats by antithrombin III. In: Müller-Berghaus G, ed. DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation Amsterdam: Elsevier 1993: 215-219
22 Dickneite G, Leithäuser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol . 1999; 19 1566-1572
23 Marcum J A, McKenney J B, Rosenberg R D. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest . 1984; 74 341-350
24 de Agostini A, Watkins S C, Slayter H S, Youssoufian H, Rosenberg R D. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol . 1990; 111 1293-1304
25 Heyderman R S, Klein N J, Shennan G I, Levin M. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay. Thromb Res . 1992; 67 677-685
26 Merkle C J, Wilson L M, Baldwin A L. Acute blood stasis reduces interstitial uptake of albumin from intestinal microcirculatory networks. Am J Physiol . 1998; 274 H600-H608
27 Ostrovsky L, Woodman R C, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation . 1997; 96 2302-2310
28 Toothil V J, van Mourik A J, Niewenhuis H K, Metzelaar M J, Pearson J D. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol . 1990; 145 283-291
29 Garcia J GN, Pavalko F M, Patterson C E. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis . 1995; 6 609-626
30 Lum H, Andersen T T, Siflinger-Birnboim A. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization. J Cell Biol . 1993; 120 1491-1499
31 Kameda H, Morita I, Handa M. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. Br J Haematol . 1997; 97 348-355
32 Taylor F B, Chang A CK, Peer G T. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood . 1991; 78 364-368
33 Siebeck M, Spannagl M, Bichler J. Delayed treatment with desulfato-hirudin prevents fibrin formation in lipopolysaccharide-induced shock. Thromb Res . 1997; 88 473-480
34 Eriksson M, Larsson A, Saldeen T, Mattsson C. Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig. Thromb Haemost . 1998; 80 1022-1026
35 Gray E, Souter P, Römisch J, Poole S. Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin. Crit Care (Abst) . 2000; 4(Suppl 1) S16-S17
36 Dunzendorfer S, Rabensteiner A, Reinisch C, Römisch J, Wiedermann C J. Inhibition of neutrophil migration by the serpin antithrombin III. Crit Care (Abst) . 2000; 4(Suppl 1) S16
37 Horie S, Ishii H, Kazama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res . 1990; 59 895-904
38 Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun . 1989; 163 1404-1411
39 Ley K, Cerrito M, Arfors K E. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol . 2000; 260 H1667-H1673
40 Xie X, Thorlacius H, Raud J, Hedqvist P, Lindbom L. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo. Br J Pharmacol . 1997; 122 906-910
41 Garred P, Mollnes T E. Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules. Artif Organs . 1997; 21 293-299
42 Nelson R M, Cecconi O, Roberts W G. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood . 1993; 82 3253-3258
43 Peter K, Schwarz M, Conradt C. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/ CD18). Circulation . 1999; 100 1533-1539